Secular Trend in GFR Decline in Non-Dialysis CKD Based on Observational Data From Standard of Care Arms of Trials
The standard of care (SoC) group of randomized controlled trials (RCTs) is a useful setting to explore the secular trends in kidney disease progression because implementation of best clinical practices is pursued for all patients enrolled in trials. This meta-analysis evaluated the secular trend in...
Gespeichert in:
| Veröffentlicht in: | American journal of kidney diseases 2024-04, Vol.83 (4), p.435-444.e1 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 444.e1 |
|---|---|
| container_issue | 4 |
| container_start_page | 435 |
| container_title | American journal of kidney diseases |
| container_volume | 83 |
| creator | Garofalo, Carlo Borrelli, Silvio Liberti, Maria Elena Chiodini, Paolo Peccarino, Laura Pennino, Luigi Polese, Lucio De Gregorio, Ilaria Scognamiglio, Mariarosaria Ruotolo, Chiara Provenzano, Michele Conte, Giuseppe Minutolo, Roberto De Nicola, Luca |
| description | The standard of care (SoC) group of randomized controlled trials (RCTs) is a useful setting to explore the secular trends in kidney disease progression because implementation of best clinical practices is pursued for all patients enrolled in trials. This meta-analysis evaluated the secular trend in the change of glomerular filtration rate (GFR) decline in the SoC arm of RCTs in chronic kidney disease (CKD) published in the last 30 years.
Systematic review and meta-analysis of the SoC arms of RCTs analyzed as an observational study.
Adult patients with CKD enrolled in the SoC arm of RCTs.
Phase 3 RCTs evaluating GFR decline as an outcome in SoC arms.
Two independent reviewers evaluated RCTs for eligibility and extracted relevant data.
The mean of GFR declines extracted in the SoC arm of selected RCTs were pooled by using a random effects model. Meta-regression analyses were performed to identify factors that may explain heterogeneity.
The SoC arms from 92 RCTs were included in the meta-analysis with a total of 32,202 patients. The overall mean GFR decline was−4.00 (95% CI, −4.55 to−3.44) mL/min/1.73m2 per year in the SoC arms with a high level of heterogeneity (I2, 98.4% [95% CI, 98.2-98.5], P |
| doi_str_mv | 10.1053/j.ajkd.2023.09.014 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2892012711</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0272638623008995</els_id><sourcerecordid>2892012711</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-b836ab1541f4296391121d0e305df176e9a8f85864f29ea362a906b72e266b293</originalsourceid><addsrcrecordid>eNp9kM1O3DAUha0KVKbQF-ii8pJNgn8SJ5bY0JkOIBBIMF1bN_GN5CGxqZ1B4m14lj5ZEw3tktXVkc75pPsR8o2znLNSnm1z2D7ZXDAhc6ZzxotPZMFLITNVy_qALJioRKZkrY7Il5S2jDEtlfpMjmSlS6VLuSDxEdtdD5FuInpLnaeX6we6wrZ3Hud4F3y2ctC_Jpfo8mZFf0BC--cteHrfJIwvMLrgoacrGIGuYxjo4wjeQrQ0dHQJEelFHNIcNnECpRNy2E0Hv77fY_Jr_XOzvMpu7y-vlxe3WVswNmZNLRU0vCx4VwitpOZccMtQstJ2vFKooe7qslZFJzSCVAI0U00lUCjVCC2Pyeme-xzD7x2m0Qwutdj34DHskhG1FoyLivOpKvbVNoaUInbmOboB4qvhzMyuzdbMrs3s2jBtJtfT6Ps7f9cMaP9P_smdCuf7Ak5fvjiMJrUOfYvWRWxHY4P7iP8XJV6OIg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2892012711</pqid></control><display><type>article</type><title>Secular Trend in GFR Decline in Non-Dialysis CKD Based on Observational Data From Standard of Care Arms of Trials</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Garofalo, Carlo ; Borrelli, Silvio ; Liberti, Maria Elena ; Chiodini, Paolo ; Peccarino, Laura ; Pennino, Luigi ; Polese, Lucio ; De Gregorio, Ilaria ; Scognamiglio, Mariarosaria ; Ruotolo, Chiara ; Provenzano, Michele ; Conte, Giuseppe ; Minutolo, Roberto ; De Nicola, Luca</creator><creatorcontrib>Garofalo, Carlo ; Borrelli, Silvio ; Liberti, Maria Elena ; Chiodini, Paolo ; Peccarino, Laura ; Pennino, Luigi ; Polese, Lucio ; De Gregorio, Ilaria ; Scognamiglio, Mariarosaria ; Ruotolo, Chiara ; Provenzano, Michele ; Conte, Giuseppe ; Minutolo, Roberto ; De Nicola, Luca</creatorcontrib><description>The standard of care (SoC) group of randomized controlled trials (RCTs) is a useful setting to explore the secular trends in kidney disease progression because implementation of best clinical practices is pursued for all patients enrolled in trials. This meta-analysis evaluated the secular trend in the change of glomerular filtration rate (GFR) decline in the SoC arm of RCTs in chronic kidney disease (CKD) published in the last 30 years.
Systematic review and meta-analysis of the SoC arms of RCTs analyzed as an observational study.
Adult patients with CKD enrolled in the SoC arm of RCTs.
Phase 3 RCTs evaluating GFR decline as an outcome in SoC arms.
Two independent reviewers evaluated RCTs for eligibility and extracted relevant data.
The mean of GFR declines extracted in the SoC arm of selected RCTs were pooled by using a random effects model. Meta-regression analyses were performed to identify factors that may explain heterogeneity.
The SoC arms from 92 RCTs were included in the meta-analysis with a total of 32,202 patients. The overall mean GFR decline was−4.00 (95% CI, −4.55 to−3.44) mL/min/1.73m2 per year in the SoC arms with a high level of heterogeneity (I2, 98.4% [95% CI, 98.2-98.5], P<0.001). Meta-regression analysis showed an association between publication year (β estimate, 0.09 [95% CI, 0.032-0.148], P=0.003) and reduction in GFR over time. When evaluating publication decade categorically, GFR decline was−5.44 (95% CI, −7.15 to−3.73), −3.92 (95% CI, −4.82 to−3.02), and −3.20 (95% CI, −3.75 to −2.64) mL/min/1.73m2 per year during 1991-2000, 2001-2010, and 2011-2023, respectively. Using meta-regression, the heterogeneity of GFR decline was mainly explained by age and proteinuria.
Different methods assessing GFR in selected trials and observational design of the study.
In the last 3 decades, GFR decline has decreased over time in patients enrolled in RCTs who received the standard of care.
Registered at PROSPERO with record number CRD42022357704.
This study evaluated the secular trend in the change in glomerular filtration rate (GFR) decline in the placebo arms of randomized controlled trials (RCTs) that were studying approaches to protect the kidneys in the setting of chronic kidney disease. The placebo groups of RCTs are useful for examining whether the rate of progression of kidney disease has changed over time. We found an improvement in the slope of change in GFR over time. These findings suggest that adherence to standards of kidney care as implemented in clinical trials may be associated with improved clinical outcomes, and these data may inform the design of future RCTs in nephrology.
[Display omitted]</description><identifier>ISSN: 0272-6386</identifier><identifier>ISSN: 1523-6838</identifier><identifier>EISSN: 1523-6838</identifier><identifier>DOI: 10.1053/j.ajkd.2023.09.014</identifier><identifier>PMID: 37956953</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>CKD ; Disease Progression ; GFR decline ; Glomerular Filtration Rate ; Humans ; meta-analysis ; nephroprotection ; Observational Studies as Topic ; Randomized Controlled Trials as Topic ; RCT ; Renal Insufficiency, Chronic - physiopathology ; Standard of Care - trends</subject><ispartof>American journal of kidney diseases, 2024-04, Vol.83 (4), p.435-444.e1</ispartof><rights>2023 The Authors</rights><rights>Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-b836ab1541f4296391121d0e305df176e9a8f85864f29ea362a906b72e266b293</citedby><cites>FETCH-LOGICAL-c400t-b836ab1541f4296391121d0e305df176e9a8f85864f29ea362a906b72e266b293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1053/j.ajkd.2023.09.014$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37956953$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Garofalo, Carlo</creatorcontrib><creatorcontrib>Borrelli, Silvio</creatorcontrib><creatorcontrib>Liberti, Maria Elena</creatorcontrib><creatorcontrib>Chiodini, Paolo</creatorcontrib><creatorcontrib>Peccarino, Laura</creatorcontrib><creatorcontrib>Pennino, Luigi</creatorcontrib><creatorcontrib>Polese, Lucio</creatorcontrib><creatorcontrib>De Gregorio, Ilaria</creatorcontrib><creatorcontrib>Scognamiglio, Mariarosaria</creatorcontrib><creatorcontrib>Ruotolo, Chiara</creatorcontrib><creatorcontrib>Provenzano, Michele</creatorcontrib><creatorcontrib>Conte, Giuseppe</creatorcontrib><creatorcontrib>Minutolo, Roberto</creatorcontrib><creatorcontrib>De Nicola, Luca</creatorcontrib><title>Secular Trend in GFR Decline in Non-Dialysis CKD Based on Observational Data From Standard of Care Arms of Trials</title><title>American journal of kidney diseases</title><addtitle>Am J Kidney Dis</addtitle><description>The standard of care (SoC) group of randomized controlled trials (RCTs) is a useful setting to explore the secular trends in kidney disease progression because implementation of best clinical practices is pursued for all patients enrolled in trials. This meta-analysis evaluated the secular trend in the change of glomerular filtration rate (GFR) decline in the SoC arm of RCTs in chronic kidney disease (CKD) published in the last 30 years.
Systematic review and meta-analysis of the SoC arms of RCTs analyzed as an observational study.
Adult patients with CKD enrolled in the SoC arm of RCTs.
Phase 3 RCTs evaluating GFR decline as an outcome in SoC arms.
Two independent reviewers evaluated RCTs for eligibility and extracted relevant data.
The mean of GFR declines extracted in the SoC arm of selected RCTs were pooled by using a random effects model. Meta-regression analyses were performed to identify factors that may explain heterogeneity.
The SoC arms from 92 RCTs were included in the meta-analysis with a total of 32,202 patients. The overall mean GFR decline was−4.00 (95% CI, −4.55 to−3.44) mL/min/1.73m2 per year in the SoC arms with a high level of heterogeneity (I2, 98.4% [95% CI, 98.2-98.5], P<0.001). Meta-regression analysis showed an association between publication year (β estimate, 0.09 [95% CI, 0.032-0.148], P=0.003) and reduction in GFR over time. When evaluating publication decade categorically, GFR decline was−5.44 (95% CI, −7.15 to−3.73), −3.92 (95% CI, −4.82 to−3.02), and −3.20 (95% CI, −3.75 to −2.64) mL/min/1.73m2 per year during 1991-2000, 2001-2010, and 2011-2023, respectively. Using meta-regression, the heterogeneity of GFR decline was mainly explained by age and proteinuria.
Different methods assessing GFR in selected trials and observational design of the study.
In the last 3 decades, GFR decline has decreased over time in patients enrolled in RCTs who received the standard of care.
Registered at PROSPERO with record number CRD42022357704.
This study evaluated the secular trend in the change in glomerular filtration rate (GFR) decline in the placebo arms of randomized controlled trials (RCTs) that were studying approaches to protect the kidneys in the setting of chronic kidney disease. The placebo groups of RCTs are useful for examining whether the rate of progression of kidney disease has changed over time. We found an improvement in the slope of change in GFR over time. These findings suggest that adherence to standards of kidney care as implemented in clinical trials may be associated with improved clinical outcomes, and these data may inform the design of future RCTs in nephrology.
[Display omitted]</description><subject>CKD</subject><subject>Disease Progression</subject><subject>GFR decline</subject><subject>Glomerular Filtration Rate</subject><subject>Humans</subject><subject>meta-analysis</subject><subject>nephroprotection</subject><subject>Observational Studies as Topic</subject><subject>Randomized Controlled Trials as Topic</subject><subject>RCT</subject><subject>Renal Insufficiency, Chronic - physiopathology</subject><subject>Standard of Care - trends</subject><issn>0272-6386</issn><issn>1523-6838</issn><issn>1523-6838</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1O3DAUha0KVKbQF-ii8pJNgn8SJ5bY0JkOIBBIMF1bN_GN5CGxqZ1B4m14lj5ZEw3tktXVkc75pPsR8o2znLNSnm1z2D7ZXDAhc6ZzxotPZMFLITNVy_qALJioRKZkrY7Il5S2jDEtlfpMjmSlS6VLuSDxEdtdD5FuInpLnaeX6we6wrZ3Hud4F3y2ctC_Jpfo8mZFf0BC--cteHrfJIwvMLrgoacrGIGuYxjo4wjeQrQ0dHQJEelFHNIcNnECpRNy2E0Hv77fY_Jr_XOzvMpu7y-vlxe3WVswNmZNLRU0vCx4VwitpOZccMtQstJ2vFKooe7qslZFJzSCVAI0U00lUCjVCC2Pyeme-xzD7x2m0Qwutdj34DHskhG1FoyLivOpKvbVNoaUInbmOboB4qvhzMyuzdbMrs3s2jBtJtfT6Ps7f9cMaP9P_smdCuf7Ak5fvjiMJrUOfYvWRWxHY4P7iP8XJV6OIg</recordid><startdate>202404</startdate><enddate>202404</enddate><creator>Garofalo, Carlo</creator><creator>Borrelli, Silvio</creator><creator>Liberti, Maria Elena</creator><creator>Chiodini, Paolo</creator><creator>Peccarino, Laura</creator><creator>Pennino, Luigi</creator><creator>Polese, Lucio</creator><creator>De Gregorio, Ilaria</creator><creator>Scognamiglio, Mariarosaria</creator><creator>Ruotolo, Chiara</creator><creator>Provenzano, Michele</creator><creator>Conte, Giuseppe</creator><creator>Minutolo, Roberto</creator><creator>De Nicola, Luca</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202404</creationdate><title>Secular Trend in GFR Decline in Non-Dialysis CKD Based on Observational Data From Standard of Care Arms of Trials</title><author>Garofalo, Carlo ; Borrelli, Silvio ; Liberti, Maria Elena ; Chiodini, Paolo ; Peccarino, Laura ; Pennino, Luigi ; Polese, Lucio ; De Gregorio, Ilaria ; Scognamiglio, Mariarosaria ; Ruotolo, Chiara ; Provenzano, Michele ; Conte, Giuseppe ; Minutolo, Roberto ; De Nicola, Luca</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-b836ab1541f4296391121d0e305df176e9a8f85864f29ea362a906b72e266b293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CKD</topic><topic>Disease Progression</topic><topic>GFR decline</topic><topic>Glomerular Filtration Rate</topic><topic>Humans</topic><topic>meta-analysis</topic><topic>nephroprotection</topic><topic>Observational Studies as Topic</topic><topic>Randomized Controlled Trials as Topic</topic><topic>RCT</topic><topic>Renal Insufficiency, Chronic - physiopathology</topic><topic>Standard of Care - trends</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Garofalo, Carlo</creatorcontrib><creatorcontrib>Borrelli, Silvio</creatorcontrib><creatorcontrib>Liberti, Maria Elena</creatorcontrib><creatorcontrib>Chiodini, Paolo</creatorcontrib><creatorcontrib>Peccarino, Laura</creatorcontrib><creatorcontrib>Pennino, Luigi</creatorcontrib><creatorcontrib>Polese, Lucio</creatorcontrib><creatorcontrib>De Gregorio, Ilaria</creatorcontrib><creatorcontrib>Scognamiglio, Mariarosaria</creatorcontrib><creatorcontrib>Ruotolo, Chiara</creatorcontrib><creatorcontrib>Provenzano, Michele</creatorcontrib><creatorcontrib>Conte, Giuseppe</creatorcontrib><creatorcontrib>Minutolo, Roberto</creatorcontrib><creatorcontrib>De Nicola, Luca</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of kidney diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Garofalo, Carlo</au><au>Borrelli, Silvio</au><au>Liberti, Maria Elena</au><au>Chiodini, Paolo</au><au>Peccarino, Laura</au><au>Pennino, Luigi</au><au>Polese, Lucio</au><au>De Gregorio, Ilaria</au><au>Scognamiglio, Mariarosaria</au><au>Ruotolo, Chiara</au><au>Provenzano, Michele</au><au>Conte, Giuseppe</au><au>Minutolo, Roberto</au><au>De Nicola, Luca</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Secular Trend in GFR Decline in Non-Dialysis CKD Based on Observational Data From Standard of Care Arms of Trials</atitle><jtitle>American journal of kidney diseases</jtitle><addtitle>Am J Kidney Dis</addtitle><date>2024-04</date><risdate>2024</risdate><volume>83</volume><issue>4</issue><spage>435</spage><epage>444.e1</epage><pages>435-444.e1</pages><issn>0272-6386</issn><issn>1523-6838</issn><eissn>1523-6838</eissn><abstract>The standard of care (SoC) group of randomized controlled trials (RCTs) is a useful setting to explore the secular trends in kidney disease progression because implementation of best clinical practices is pursued for all patients enrolled in trials. This meta-analysis evaluated the secular trend in the change of glomerular filtration rate (GFR) decline in the SoC arm of RCTs in chronic kidney disease (CKD) published in the last 30 years.
Systematic review and meta-analysis of the SoC arms of RCTs analyzed as an observational study.
Adult patients with CKD enrolled in the SoC arm of RCTs.
Phase 3 RCTs evaluating GFR decline as an outcome in SoC arms.
Two independent reviewers evaluated RCTs for eligibility and extracted relevant data.
The mean of GFR declines extracted in the SoC arm of selected RCTs were pooled by using a random effects model. Meta-regression analyses were performed to identify factors that may explain heterogeneity.
The SoC arms from 92 RCTs were included in the meta-analysis with a total of 32,202 patients. The overall mean GFR decline was−4.00 (95% CI, −4.55 to−3.44) mL/min/1.73m2 per year in the SoC arms with a high level of heterogeneity (I2, 98.4% [95% CI, 98.2-98.5], P<0.001). Meta-regression analysis showed an association between publication year (β estimate, 0.09 [95% CI, 0.032-0.148], P=0.003) and reduction in GFR over time. When evaluating publication decade categorically, GFR decline was−5.44 (95% CI, −7.15 to−3.73), −3.92 (95% CI, −4.82 to−3.02), and −3.20 (95% CI, −3.75 to −2.64) mL/min/1.73m2 per year during 1991-2000, 2001-2010, and 2011-2023, respectively. Using meta-regression, the heterogeneity of GFR decline was mainly explained by age and proteinuria.
Different methods assessing GFR in selected trials and observational design of the study.
In the last 3 decades, GFR decline has decreased over time in patients enrolled in RCTs who received the standard of care.
Registered at PROSPERO with record number CRD42022357704.
This study evaluated the secular trend in the change in glomerular filtration rate (GFR) decline in the placebo arms of randomized controlled trials (RCTs) that were studying approaches to protect the kidneys in the setting of chronic kidney disease. The placebo groups of RCTs are useful for examining whether the rate of progression of kidney disease has changed over time. We found an improvement in the slope of change in GFR over time. These findings suggest that adherence to standards of kidney care as implemented in clinical trials may be associated with improved clinical outcomes, and these data may inform the design of future RCTs in nephrology.
[Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>37956953</pmid><doi>10.1053/j.ajkd.2023.09.014</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0272-6386 |
| ispartof | American journal of kidney diseases, 2024-04, Vol.83 (4), p.435-444.e1 |
| issn | 0272-6386 1523-6838 1523-6838 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2892012711 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | CKD Disease Progression GFR decline Glomerular Filtration Rate Humans meta-analysis nephroprotection Observational Studies as Topic Randomized Controlled Trials as Topic RCT Renal Insufficiency, Chronic - physiopathology Standard of Care - trends |
| title | Secular Trend in GFR Decline in Non-Dialysis CKD Based on Observational Data From Standard of Care Arms of Trials |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T06%3A29%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Secular%20Trend%20in%20GFR%20Decline%20in%20Non-Dialysis%20CKD%20Based%C2%A0on%20Observational%20Data%20From%20Standard%20of%20Care%20Arms%20of%20Trials&rft.jtitle=American%20journal%20of%20kidney%20diseases&rft.au=Garofalo,%20Carlo&rft.date=2024-04&rft.volume=83&rft.issue=4&rft.spage=435&rft.epage=444.e1&rft.pages=435-444.e1&rft.issn=0272-6386&rft.eissn=1523-6838&rft_id=info:doi/10.1053/j.ajkd.2023.09.014&rft_dat=%3Cproquest_cross%3E2892012711%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2892012711&rft_id=info:pmid/37956953&rft_els_id=S0272638623008995&rfr_iscdi=true |